ARTICLE | Clinical News
Forest reports positive Phase III data
May 7, 2001 7:00 AM UTC
FRX said data from a 491-patient Phase III study showed escitalopram, a single isomer of Celexa citalopram selective serotonin reuptake inhibitor (SSRI) to treat depression, was significantly better t...